enVVeno Medical Corp
NVNO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001661053
In the last 90 days, enVVeno Medical Corp insiders filed 0 open-market purchases and 1 sale; 17 institutions reported holding it in 13F filings for Q2 2026, worth $953.6K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding enVVeno Medical Corp changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 21 | 21 | 0 |
| Shares | 2.04M | 2.15M | +107.4K (+5.3%) |
| Value | $13.0M | $8.11M | −$4.87M (−37.5%) |
New holders (3)
Institutions that held enVVeno Medical Corp at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Oconnor LLC | 118,113 | $446.0K | 0.00% |
| Susquehanna International Group, LLP | 11,169 | $42.0K | 0.00% |
| Sepio Capital, LP | 10,800 | $41.0K | 0.00% |
Sold out (3)
Institutions that held enVVeno Medical Corp at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Kepos Capital LP | 50,000 | $319.0K |
| Two Sigma Investments, LP | 33,372 | $213.0K |
| PEAK6 Investments LLC | 1,861 | $12.0K |